GALECTIN-3 - ANVISA Registration 80146501921
Access comprehensive regulatory information for GALECTIN-3 in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80146501921 and manufactured by ABBOTT GMBH. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 1 companies making the same product including ABBOTT GMBH, and 3 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
80146501921
25351664487201476
56998701000116
Company Information
Dates and Status
Mar 02, 2015
VIGENTE
09/18/2025 19:00:01
THYROGLOBULIN (TG)
ARCHITECT ANTI-TG CONTROLS / ARCHITECT ANTI-TG CONTROLES
ABBOTT IRELAND DIAGNOSTIC DIVISION
80146501395
Dec 26, 2006
CARCINOEMBRYONIC ANTIGEN
ARCHITECT CEA Controls
ABBOTT IRELAND DIAGNOSTIC DIVISION
10055311074
Apr 02, 2001
CARCINOEMBRYONIC ANTIGEN
ARCHITECT CEA Controls
Not specified
10055311074
Apr 02, 2001
C-PEPTIDE
ARCHITECT C PEPTIDE CONTROLS
ABBOTT GMBH
80146501560
Oct 27, 2008
C-PEPTIDE
ARCHITECT C PEPTIDE CONTROLS
ABBOTT LABORATORIES
80146501560
Oct 27, 2008
GALECTINA-3
Família Alinity i Galectin-3
ABBOTT GMBH
80146502278
Aug 31, 2020
GALECTINA-3
ARCHITECT Galectin-3 Calibrators
ABBOTT GMBH
80146501920
Mar 02, 2015
GALECTINA-3
ARCHITECT Galectin-3 Reagent Kit
ABBOTT GMBH
80146501922
Mar 02, 2015